Abstract:
A pigment dispersing polymer comprising a backbone having one or more urea groups and having polymeric side chains extending therefrom. The dispersing polymer may be formed from the reaction of a compound having one or more carbodiimide groups with acid functional resins such as acid functional polyesters, acid functional acrylics, acid functional polyethers, and fatty acids.
Abstract:
Compounds which inhibit the activity of anti-apoptotic family protein members, compositions containing the compounds and methods of treating diseases during which occur expression one or more than one of an anti-apoptotic family protein member are disclosed.
Abstract:
Compounds which inhibit the activity of anti-apoptotic family protein members, compositions containing the compounds and methods of treating diseases during which occur expression one or more than one of an anti-apoptotic family protein member are disclosed.
Abstract:
Disclosed are compounds which inhibit the activity of anti-apoptotic protein family members, compositions containing the compounds and uses of the compounds for preparing medicaments for treating diseases during which occurs expression one or more than one of an anti-apoptotic protein family member.
Abstract:
The invention relates to a communication method between a fixed telephone and a PHS mobile phone by means of a two-way conversation function, which comprises the steps of registering a PHS mobile phone and a fixed telephone having a PHS mobile two-way communication module installed therein in the same subsystem group to get connected, such that the PHS mobile phone and the fixed telephone can communicate with each other via a wireless channel interface; using the PHS mobile phone to send a voice to the fixed telephone; using the fixed telephone to send the voice to a communication terminal of the opposite party and then to the user's PHS mobile phone via the conversation mode; and enabling the PHS mobile phone to receive the incoming call of the fixed telephone or dial a telephone call via the fixed telephone.
Abstract:
Methods for treating metal substrates are disclosed. These methods, which comprise contacting the surface to be treated with a composition comprising a Mannich-derivatized polyether, improve the corrosion resistance and/or adhesion properties of the treated surface. Similar methods for treating polymeric substrates are disclosed.
Abstract:
The present invention provides novel, long-acting nanoformulated drugs and targeted drug delivery methods, and uses thereof. In one embodiment, the nanoformulated drug is a retroviral drug. In one embodiment, the nanoformulated composition comprises a nanocarrier with one or more incorporated drugs. In an exemplary embodiment, the drug is efavirenz (EFV). In a further embodiment, the nanocarrier is associated with an agent for targeting microfold cells (M-cells). In a specific embodiment, the targeting agent binds to an M-cell marker known as glycoprotein 2 (GP2). Via this mechanism, the nanodrug is targeted toward GALT.
Abstract:
An integrated interactively teaching platform system comprising a pre-class interactive data compiling device, a in-class interactive data compiling device, and an after-class interactive data assessing device, wherein the pre-class interactive data compiling device generates an interactive teaching plan and an evaluating test paper object which can be used in class by the in-class interactive data compiling device. The in-class interactive data compiling device performs a teaching service and an evaluation test with an evaluating test paper object, and tracks the evaluating test paper object to obtain an evaluation result. The after-class interactive data assessing device generates an assessing record according to the evaluation result to provide teachers with the current study status of students.
Abstract:
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 or Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti-apoptotic Bcl-2 protein.
Abstract:
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 or Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti-apoptotic Bcl-2 protein.